Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125234) titled 'A multicenter randomized controlled trial of prophylactic intraperitoneal normothermic chemotherapy for resectable locally advanced gastric/gastroesophageal junction adenocarcinoma (cT4a >= 4 cm or cN2-3)' on May 22.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Condition: Resectable locally advanced gastric/gastric-cardiac junction adenocarcinoma (cT4a >= 4cm or cN2-3)

Intervention: Experimental group:Intraoperative placement of the abdominal chemotherapy port and postoperative prophylactic intraperitoneal normothe...